Skip to Main Content

Melissa Hines, MD

Associate Member, St. Jude Faculty

Director, Histiocytosis and Immune Dysregulation Team

On this page:

Contact Information

Melissa Hines, MD

Critical Care Medicine

MS 734, Room IA3305

St. Jude Children's Research Hospital

262 Danny Thomas Place

MemphisTN 38105-3678

Education

BS - Christian Brothers University, Memphis, TN

MD - University of Tennessee Health Science Center, Memphis, TN

Resident (General Pediatrics) - Le Bonheur Children’s Hospital, St Jude Children’s Research Hospital, University of Tennessee Health Science Center, Memphis, TN

Fellow (Pediatric Critical Care Medicine) - North Carolina Children’s Hospital, University of North Carolina Hospitals, Chapel Hill, NC

Honors & Awards

  • 2016  Amal Murarka Pediatric Teaching Award, University of North Carolina, Department of Pediatrics
  • 2010  Faculty Medal for Highest Academic Achievement, University of Tennessee, award given to medical school graduate with highest grade point average
  • 2009  Albright Armstrong Rice Scholarship, University of Tennessee, scholarship awarded based on academic merit
  • 2009  American Medical Association Scholars Fund, University of Tennessee, scholarship awarded based on academic merit
  • 2006 to 2008  Alumni Merit Scholarship, University of Tennessee, scholarship awarded based on academic merit

Research Interests

  • Hemophagocytic lymphohistiocytosis (HLH)
  • Use of new therapies for HLH
  • Immune system dysregulation in pediatric hematology/oncology patients during critical illness including hyperinflammation and thrombotic microangiopathy (TMA)
  • Use of cytokine inhibition and biologic therapies in pediatric critical illness
  • Immune-effector cell associated hemophagocytic syndrome (IEC-HS) and immune-effector cell associated cytokine release syndrome (CRS)

Clinical Trials

Recruiting
HSESID: Database for HLH Immunodeficiency Disease

Study goal:

The main goal of the study is to create an international database of HLH patient information. This information will help researchers develop clinical trials in the future on new HLH treatments.

St. Jude Publications